ADAR and neoplasm: To test this hypothesis, we injected diploid- and tetraploid-sorted TBP ARPE cells with or without stable ADAR1 knockdown under the skin of immune-compromised NMRI mice, which lack T-cells, and monitored tumor outgrowth over time.